Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for acute type A aortic dissection without surgical indication
ChiCTR2300069273Phase 2Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of coenzyme q10 in aortic dissection (3 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: All-cause mortality. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
coenzyme q10
03
Conditions
aortic dissection
Beyond the preview
Go deeper on ChiCTR2300069273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069273.